- Filed
- Nov 12, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2021 · Nov 12, 2021 | 9.11M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 9.22M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2021 | 9.25M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 9.48M sh |
| Shares Diluted | Q3 2021 · Sep 30, 2020 | 9.59M sh |
| Dividends Paid | Q3 2021 · Sep 30, 2021 | $693.74K |
| Dividends Paid | Q3 2021 · Sep 30, 2020 | $922.53K |
| Capex | Q3 2021 · Sep 30, 2021 | $823.67K |
| Capex restated | Q3 2021 · Sep 30, 2020 | $529.04K |
| Operating Cash Flow | Q3 2021 · Sep 30, 2021 | $8.8M |
| Operating Cash Flow restated | Q3 2021 · Sep 30, 2020 | $11.96M |
| Long Term Debt | Q3 2021 · Sep 30, 2021 | $2M |
| Long Term Debt | Q3 2021 · Dec 31, 2020 | $3.11M |
| Short Term Investments | Q3 2021 · Sep 30, 2021 | $36.83M |
| Short Term Investments | Q3 2021 · Dec 31, 2020 | $17.09M |
| Cash And Equivalents | Q3 2021 · Sep 30, 2021 | $13.02M |
| Cash And Equivalents | Q3 2021 · Dec 31, 2020 | $32.5M |
| Cash And Equivalents restated | Q3 2021 · Sep 30, 2020 | $30.27M |
| Cash And Equivalents restated | Q3 2021 · Dec 31, 2019 | $27.16M |
| Stockholders Equity | Q3 2021 · Sep 30, 2021 | $75.64M |
| Stockholders Equity | Q3 2021 · Dec 31, 2020 | $68.03M |
| Current Liabilities | Q3 2021 · Sep 30, 2021 | $22.56M |
| Current Liabilities | Q3 2021 · Dec 31, 2020 | $19.22M |
| Total Liabilities | Q3 2021 · Sep 30, 2021 | $36.66M |
| Total Liabilities | Q3 2021 · Dec 31, 2020 | $33.55M |
| Current Assets | Q3 2021 · Sep 30, 2021 | $73.28M |
| Current Assets | Q3 2021 · Dec 31, 2020 | $68.15M |
| Total Assets | Q3 2021 · Sep 30, 2021 | $114.06M |
| Total Assets | Q3 2021 · Dec 31, 2020 | $103.14M |
| Total Assets restated | Q3 2021 · Sep 30, 2020 | $103K |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $0.11 |
| Eps Diluted | Q3 2021 · Sep 30, 2021 | $1.01 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.12 |
| Eps Diluted | Q3 2021 · Sep 30, 2020 | $0.83 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $0.11 |
| Eps Basic | Q3 2021 · Sep 30, 2021 | $1.01 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.12 |
| Eps Basic | Q3 2021 · Sep 30, 2020 | $0.83 |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $2.44M |
| Sga Expense | Q3 2021 · Sep 30, 2021 | $7.23M |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $2.13M |
| Sga Expense restated | Q3 2021 · Sep 30, 2020 | $8.28M |
| Operating Income | Q3 2021 · Sep 30, 2021 | $2.17M |
| Operating Income | Q3 2021 · Sep 30, 2021 | $14.66M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $2.23M |
| Operating Income restated | Q3 2021 · Sep 30, 2020 | $12.05M |
| Gross Profit | Q3 2021 · Sep 30, 2021 | $18.27M |
| Gross Profit | Q3 2021 · Sep 30, 2021 | $63.83M |
| Gross Profit restated | Q3 2021 · Sep 30, 2020 | $17.25M |
| Gross Profit restated | Q3 2021 · Sep 30, 2020 | $61.58M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $18.14M |
| Cost Of Revenue | Q3 2021 · Sep 30, 2021 | $60.67M |
| Cost Of Revenue restated | Q3 2021 · Sep 30, 2020 | $17.47M |
| Cost Of Revenue restated | Q3 2021 · Sep 30, 2020 | $54.57M |
| Revenue | Q3 2021 · Sep 30, 2021 | $35.29M |
| Revenue | Q3 2021 · Sep 30, 2021 | $121.5M |
| Revenue | Q3 2021 · Sep 30, 2020 | $33.3M |
| Revenue | Q3 2021 · Sep 30, 2020 | $111.52M |